Back to CERS Stock Lookup

Cerus (CERS) – Press Releases

Jan 14, 2016 08:30 AM AABB Authorizes Use of the INTERCEPT Blood System for Platelets to Reduce the Risk of Transfusion-Associated Graft Versus Host Disease
Jan 11, 2016 08:30 AM Cerus Appoints New Leadership for Europe, Middle East and Africa Region
Jan 7, 2016 08:30 AM Cerus and LifeShare Blood Centers Enter into Agreement for the Use of INTERCEPT Platelets and Plasma
Jan 5, 2016 08:30 AM Cerus Announces Agreement with Blood Systems, Inc. for the Use of INTERCEPT Platelets and Plasma
Dec 23, 2015 08:30 AM Cerus Announces Rhode Island Blood Center Enters into Agreement for the Use of INTERCEPT Platelets and Plasma
Dec 10, 2015 08:32 AM Cerus Announces Agreement with the National Transfusiology Center of Mongolia for the Use of INTERCEPT Platelets and Plasma
Dec 9, 2015 08:30 AM Cerus Announces Agência Nacional de Vigilância Sanitária Approval of the INTERCEPT Blood System for Platelets and Plasma in Brazil
Dec 8, 2015 08:30 AM First Patient Enrolled in Cerus’ Phase IV PIPER Study
Dec 7, 2015 08:30 AM Cerus and Shepeard Community Blood Center Enter into Agreement for the Use of INTERCEPT Platelets and Plasma
Dec 4, 2015 08:30 AM Cerus Announces Mississippi Valley Regional Blood Center Enters Into Agreement for the Use of INTERCEPT Platelets and Plasma
Dec 2, 2015 08:30 AM Cerus Announces Collaboration Agreement With Haemonetics for the Use of Acrodose Platelet Kits With the INTERCEPT Blood System for Platelets
Dec 1, 2015 08:30 AM Cerus and The Community Blood Center Enter into Agreement for the Use of INTERCEPT Platelets and Plasma
Nov 5, 2015 04:01 PM Cerus Corporation Reports Third Quarter 2015 Results
Nov 5, 2015 08:30 AM Cerus and OneBlood Enter into Agreement for the Use of INTERCEPT Platelets and Plasma
Nov 3, 2015 08:30 AM Cerus to Present at the Stephens 2015 Fall Investment Conference on November 10, 2015
Nov 2, 2015 08:30 AM Cerus Corporation Announces CMS Issuance of Permanent P-Codes for Outpatient Hospital Billing of Pathogen-Reduced Platelets and Plasma
Oct 26, 2015 08:30 AM Cerus to Release Third Quarter 2015 Results on November 5, 2015
Oct 21, 2015 08:30 AM Cerus Corporation Announces New Agreement With Fresenius Kabi for the Production of INTERCEPT Blood System Kits
Oct 6, 2015 08:30 AM Cerus and the Community Blood Center of the Carolinas Enter into Agreement for the Use of INTERCEPT Platelets and Plasma
Sep 10, 2015 08:30 AM Cerus to Present at the Morgan Stanley Global Healthcare Unplugged Conference on September 17, 2015
Sep 2, 2015 08:30 AM Cerus to Present at the Baird 2015 Healthcare Conference on September 9, 2015
Aug 6, 2015 04:01 PM Cerus Corporation Reports Second Quarter 2015 Results
Aug 4, 2015 08:30 AM Cerus to Present at the 2015 Wedbush PacGrow Healthcare Conference on August 11, 2015
Jul 21, 2015 08:30 AM Cerus and Unyts Enter Into Agreement for the Use of INTERCEPT Platelets and Plasma
Jul 13, 2015 08:30 AM Cerus and Bonfils Blood Center Enter Into Agreement for the Use of INTERCEPT Platelets and Plasma
Jul 6, 2015 08:30 AM Cerus to Release Second Quarter 2015 Results on August 6, 2015
Jul 1, 2015 08:30 AM Cerus to Present at Cantor Fitzgerald’s Inaugural Healthcare Conference on July 8, 2015
Jun 29, 2015 08:30 AM First INTERCEPT Pathogen Reduced Platelet Units Produced in the Continental US
Jun 8, 2015 08:30 AM Richard J. Benjamin, MD PhD Appointed as Cerus Corporation’s New Chief Medical Officer
May 5, 2015 04:01 PM Cerus Corporation Reports First Quarter 2015 Results
Apr 27, 2015 08:30 AM Cerus to Present at AABB Symposium on Pathogen-Reduced Components
Apr 22, 2015 08:30 AM Cerus to Release First Quarter 2015 Results on May 5, 2015
Mar 16, 2015 08:30 AM First Patient Enrolled in Cerus' TRUE Study With the American Red Cross to Address Chikungunya and Dengue Blood Safety Risks With Pathogen Reduced Platelets

Back to CERS Stock Lookup